~~<i id='61517F17A8'><strike id='61517F17A8'><tt id='61517F17A8'><pre id='61517F17A8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：Wikipedia 2025-10-03 00:04:03 - browse：9777

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： FDA scientists endorse Pfizer/BioNTech Covid

knowledge

focus

hotspot

focus

NASATheywereamongthehealthiestpeopleinthecountry,butseveralApolloastronautssuccumbedearlyinlifetohea

WSS

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Heart disease in astronauts blamed on cosmic radiation

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

'Null' research findings aren't empty of meaning. Let's publish them

The cancer stories no one wants to hear

New Ultima Genomics DNA sequencer can read genome for $100

hotspot

focus

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Do digital therapeutics have a future in medicine?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Alnylam reports growth in sales of rare disease treatments

ChatGPT in medicine: STAT answers readers' burning questions

Woodcock on FDA’s accelerated approval and her next chapter

Walensky prepares to leave CDC — and Congress — behind

Some dementia cases could be undiagnosed liver disease

Apple is now the first public company to be valued at $3 trillion

Medicare drug price negotiation’s day in court

focus

Florida officials tell state schools to teach AP Psychology 'in its entirety'

New Ultima Genomics DNA sequencer can read genome for $100

Pharma showers House GOP doctor with campaign cash

FDA drug safety: Singulair case shows systemic surveillance flaws

Cybersecurity threat forces Lurie Children's to take systems offline

The a glaring gap in research on serious mental illness and primary care

focus

focus

hotspot

focus